El
Posted:
June 06, 2026
Location:
toronto, on, Canada
Job Description
Join Lilly Canada as the Director of Real-World Evidence, driving strategic evidence generation and enhancing healthcare outcomes. This role features hybrid work with a strong focus on collaboration.
As the Director, you will spearhead the RWE strategy across therapeutic areas, prioritizing the delivery of high-quality evidence to meet the needs of regulators and healthcare professionals. Collaborating with teams across Clinical Development, Market Access, and more, your leadership will be pivotal in addressing key evidence gaps through innovative research methodologies. You'll also play a crucial role in mentoring juniors and advocating for advancements in RWE solutions.
Key Responsibilities:
• Develop and implement strategies for integrated evidence generation
• Lead observational study designs and pragmatic research
• Oversee partnerships with vendors and ensure timely execution
• Facilitate training on RWE insights across internal teams
• Ensure compliance and ...
As the Director, you will spearhead the RWE strategy across therapeutic areas, prioritizing the delivery of high-quality evidence to meet the needs of regulators and healthcare professionals. Collaborating with teams across Clinical Development, Market Access, and more, your leadership will be pivotal in addressing key evidence gaps through innovative research methodologies. You'll also play a crucial role in mentoring juniors and advocating for advancements in RWE solutions.
Key Responsibilities:
• Develop and implement strategies for integrated evidence generation
• Lead observational study designs and pragmatic research
• Oversee partnerships with vendors and ensure timely execution
• Facilitate training on RWE insights across internal teams
• Ensure compliance and ...
Apply for this Job
Submit your application for the Director, Real-World Evidence in Toronto position at Eli Lilly and Company.
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
toronto, Canada
Posted:
June 06, 2026
Deadline:
July 16, 2026